Enrichment analysis of genes dysregulated following Doxorubicin treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013585
TitleEnrichment analysis of genes dysregulated following Doxorubicin treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Doxorubicin treated cells and untreated control cells in the Eµ-myc transgenic lymphoma cells deficient in Suv39h1 cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3089597
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatortimkenny92
CREEDS IDdrug:2486
Cell TypeEµ-myc transgenic lymphoma cells deficient in Suv39h1
Drug NameDoxorubicin
DrugBank IDDB00997
Organismmouse
PubChem CID31703
SMILES IDCC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O
Characteristic Direction parameters
Control SamplesGSM1083870, GSM1083872, GSM1083874, GSM1083876, GSM1083878
Perturbed SamplesGSM1083871, GSM1083873, GSM1083875, GSM1083877, GSM1083879
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE44355
Gene Expression Omnibus
Adriamycin in vitro effect on E-myc transgenic lymphoma cells deficient in Suv39h1
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.